Showing results (211-220 of 274) with videos related to

Sort By:
Pageof 28
Plos One|December 17, 2013
Differential gene expression of cardiac ion channels in human dilated cardiomyopathyMaria Micaela Molina-Navarro, Esther Roselló-Lletí, Ana Ortega, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 9, 2014
RNA-sequencing analysis reveals new alterations in cardiomyocyte cytoskeletal genes in patients with heart failureIsabel Herrer, Esther Roselló-Lletí, Miguel Rivera, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 23, 2013
Association of the thrombomodulin gene c.1418C>T polymorphism with thrombomodulin levels and with venous thrombosis riskSilvia Navarro, Pilar Medina, Elena Bonet, et al.
Molecular Nutrition & Food Research|April 22, 2025
Microbial Insights: The Role of Diet in Modulating Gut Microbiota and Metabolites After Acute Coronary SyndromeRaquel López-Gálvez, Esteban Orenes-Piñero, José Miguel Rivera-Caravaca, et al.
Interactive Cardiovascular and Thoracic Surgery|June 28, 2021
Mid-term outcomes of rapid deployment aortic prostheses in patients with small aortic annulusJosé M Arribas-Leal, José Miguel Rivera-Caravaca, Ramón Aranda-Domene, et al.
Revista Espanola De Cardiologia|December 6, 2006
[8-hydroxy-2'-deoxyguanosine and lipid peroxidation in patients with heart failure]Miguel Rivera, Esther Roselló-Lletí, Fernando García de Burgos, et al.
Clinical Proteomics|April 26, 2017
A clinical perspective on the utility of alpha 1 antichymotrypsin for the early diagnosis of calcific aortic stenosisTatiana Martin-Rojas, Laura Mourino-Alvarez, Felix Gil-Dones, et al.
Echocardiography (Mount Kisco, N.Y.)|April 28, 2006
Maximum longitudinal relaxation velocity of the left ventricle: its clinical value and relationship with NT-proBNP plasma levels in heart failureRaquel Taléns-Visconti, Miguel Rivera, Vicente Climent, et al.
BMC Medical Genomics|April 18, 2015
Gene expression network analysis reveals new transcriptional regulators as novel factors in human ischemic cardiomyopathyIsabel Herrer, Esther Roselló-Lletí, Ana Ortega, et al.
Expert Opinion on Pharmacotherapy|August 4, 2022
A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registryMaría Asunción Esteve-Pastor, José Miguel Rivera-Caravaca, Martín Ruiz-Ortiz, et al.
Pageof 28